AB
Healthcare & Life Sciences
Accro Bioscience
China
Accro Bioscience is a Healthcare & Life Sciences startup based in China, most recent round Series B, 2 tracked investors.
zombieseries-b
series-b
Stage
2
Investors
About Accro Bioscience
Accro Bioscience is a company headquartered in China. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Accro Bioscience is a biopharmaceutical company focused on the research and development of innovative drugs targeting regulated cell death (RCD) pathways for treating major diseases like cancer and autoimmune disorders.
Explore Accro Bioscience's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.